🇺🇸 FDA
Pipeline program

VX-147 film-coated tablet, VX-147, Coated Placebo Tablet

VX21-147-301

Phase 3 small_molecule active

Quick answer

VX-147 film-coated tablet, VX-147, Coated Placebo Tablet for APOL1-mediated Proteinuric Kidney Disease (AMKD) is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Vertex Pharmaceuticals (Ireland) Limited
Indication
APOL1-mediated Proteinuric Kidney Disease (AMKD)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials